Asthma
📧 Sign up to get email alerts when something new happens for Asthma.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2012-12-07FDA Approved: XOPENEX HFA — Supplemental Application (Lupin Pharmaceuticals, Inc.)
FDA approved Lupin Pharmaceuticals' supplemental application for XOPENEX HFA (levalbuterol tartrate).
-
CLINICAL_TRIALS trial_result · 2012-12-06Clinical Trial Update: Lansoprazole to Treat Children With Asthma [Phase 4]
Phase 4 clinical trial evaluating lansoprazole for treating asthma in children has completed, with results posted in December 2012.
-
FDA approval · 2012-12-05FDA Approved: FLUTICASONE PROPIONATE DISKUS — Supplemental Application (Prasco Laboratories)
FDA approved a supplemental application for Fluticasone Propionate Diskus from Prasco Laboratories, approving a generic version of the inhal…
-
CLINICAL_TRIALS trial_result · 2012-12-05Clinical Trial Update: A Study of Inhalation of 20,000 EU CCRE in Normal Volunteers Compared to Allergic Asthmatic Individuals [Phase 1]
Phase 1 trial comparing inhalation of an investigational agent (CCRE) in normal volunteers and allergic asthmatics has completed.
-
CLINICAL_TRIALS trial_result · 2012-12-03Clinical Trial Update: Inhaled TPI-1020 Versus Inhaled Budesonide in Smokers With Mild Reversible Asthma [Phase 2]
A Phase 2 trial comparing inhaled TPI-1020 with inhaled budesonide in smokers with mild reversible asthma has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2012-12-03Clinical Trial Update: Multiple Dose ASM8 in Mild Asthmatics [Phase 1, Phase 2]
The trial update reports the completion of multiple-dose ASM8 studies in adults with mild asthma across Phase 1 and Phase 2.
-
CLINICAL_TRIALS withdrawal · 2012-12-03Clinical Trial Update: A Single Blind Study to Evaluate the Safety, Tolerability and Explore the Efficacy of 8.0 mg ASM8 Inhaled Daily for 14 Days in Severe Asthma [Phase 2]
A Phase 2 single-blind trial evaluating safety, tolerability and exploratory efficacy of 8.0 mg ASM8 inhaled daily for 14 days in severe ast…
-
CLINICAL_TRIALS trial_result · 2012-12-03Clinical Trial Update: Safety and Efficacy of Two Dosages of Inhaled TPI ASM8 Compared to Placebo in Mild to Moderate Asthmatic Patients [Phase 2]
Phase 2 trial comparing two inhaled doses of TPI ASM8 to placebo in mild-to-moderate asthma was terminated. The update notes safety and effi…
-
CLINICAL_TRIALS trial_result · 2012-11-30Clinical Trial Update: Study to Investigate the Efficacy of Symbicort® SMART. [Phase 3]
A Phase 3 trial evaluating Symbicort SMART for asthma has completed, and results have been posted.
-
FDA approval · 2012-11-30FDA Approved: MONTELUKAST SODIUM — Supplemental Application (Rising Pharma Holdings, Inc.)
FDA approved a supplemental application for Montelukast Sodium by Rising Pharma Holdings, Inc., enabling a generic version of Montelukast so…
-
CLINICAL_TRIALS trial_result · 2012-11-27Clinical Trial Update: Safety, Tolerability, and Pharmacokinetics After Multiple Doses of Orally Inhaled DNAzyme Solution for Nebulisation in Healthy Male Subjects [Phase 1]
Phase 1 study evaluating safety, tolerability, and pharmacokinetics after multiple doses of an inhaled DNAzyme solution delivered by nebulis…
-
CLINICAL_TRIALS trial_result · 2012-11-27Clinical Trial Update: Pharmacokinetic Study on Budesonide/Formoterol Device-metered Dry Powder Inhalers [Phase 1]
Phase 1 pharmacokinetic study of budesonide/formoterol delivered via a device-metered dry powder inhaler in asthma has completed.
-
CLINICAL_TRIALS trial_result · 2012-11-27Clinical Trial Update: A Phase 1 Study of CNTO 3157 in Healthy Volunteers and Patients With Asthma [Phase 1]
Phase 1 clinical trial update on CNTO 3157 in healthy volunteers and asthma patients; the study status is completed.
-
FDA approval · 2012-11-23FDA Approved: DULERA — Supplemental Application (Organon LLC)
The FDA approved a supplemental application for Dulera (mometasone furoate and formoterol fumarate dihydrate) from Organon LLC, updating the…
-
CLINICAL_TRIALS trial_result · 2012-11-22Clinical Trial Update: Safety, Tolerability, and Pharmacokinetics of Orally Inhaled DNAzyme Solution for Nebulisation in Healthy Male Subjects [Phase 1]
The trial evaluates safety, tolerability, and pharmacokinetics of an orally inhaled DNAzyme solution delivered by nebulization in healthy ma…
-
CLINICAL_TRIALS trial_result · 2012-11-22Clinical Trial Update: Comparison of Absorption of Budesonide and Formoterol From Budesonide/Formoterol Easyhaler and Symbicort Turbuhaler [Phase 1]
A Phase 1 study comparing the absorption of budesonide/formoterol delivered by the Easyhaler versus the Turbuhaler in asthma, which has comp…
-
CLINICAL_TRIALS trial_result · 2012-11-21Clinical Trial Update: My MediHealth: A Paradigm for Children-centered Medication Management
The completed trial evaluated a child-centered medication management program for pediatric asthma.
-
CLINICAL_TRIALS trial_result · 2012-11-20Clinical Trial Update: Qvar Therapy in Smoking Asthmatics
A completed clinical trial evaluating Qvar (beclomethasone dipropionate) inhaled corticosteroid therapy in smokers with asthma.
-
FDA approval · 2012-11-19FDA Approved: ALVESCO — Supplemental Application (Covis Pharma US, Inc)
FDA approved a supplemental application for ALVESCO (ciclesonide) from Covis Pharma US, Inc., resulting in updated labeling for the product.
-
CLINICAL_TRIALS trial_result · 2012-11-19Clinical Trial Update: Effects of Su-Huang Antitussive Capsule on Cough Variant Asthma [Phase 4]
An update on a Phase 4 trial of Su-Huang Antitussive Capsule for cough variant asthma. The trial status is listed as UNKNOWN.
-
CLINICAL_TRIALS trial_result · 2012-11-12Clinical Trial Update: Successful Control and Clinical Effectiveness Of SERETIDE(Salmeterol/Fluticasone Propionate) Study In Asthma.(SUCCESS) [Phase 4]
Phase 4 clinical trial update showing successful control and clinical effectiveness of Seretide (salmeterol/fluticasone propionate) in asthm…
-
CLINICAL_TRIALS withdrawal · 2012-11-12Clinical Trial Update: Aura Adolescent PK Study GSK2829332 [Phase 2]
The Aura Adolescent PK Study GSK2829332 (Phase 2) in asthma has been withdrawn from the trial.
-
CLINICAL_TRIALS trial_result · 2012-11-09Clinical Trial Update: Phase4/Symbicort® Versus Pulmicort Flexhaler® in African Americans [Phase 4]
A Phase 4 trial comparing Symbicort (budesonide/formoterol) with Pulmicort Flexhaler (budesonide) in African Americans with asthma has compl…
-
CLINICAL_TRIALS trial_result · 2012-11-09Clinical Trial Update: Hyperpolarized Noble Gas MR Imaging for Pulmonary Disorders [NA]
The clinical trial examining hyperpolarized noble gas MRI for pulmonary disorders, including COPD and cystic fibrosis, was terminated with r…
-
CLINICAL_TRIALS research · 2012-11-09Clinical Trial Update: The Provider and Organization in Asthma Guidelines [NA]
A completed clinical trial evaluating the role of providers and organizations in asthma guidelines.